Dyna-RR-DTC model: integrating clinicopathological features with dynamic indicators to predict radioiodine-refractory differentiated thyroid cancer risk
Shi-qi Chen, Wei Jiang, Peng-qing Wu, Xue-zhong Chen, Qing Zhang. Dyna-RR-DTC model: integrating clinicopathological features with dynamic indicators to predict radioiodine-refractory differentiated thyroid cancer risk. // Annals of Nuclear Medicine. – 2025. – DOI: 10.1007/s12149-025-02119-3. – URL: https://doi.org/10.1007/s12149-025-02119-3
Shi-qi Chen, Wei Jiang, Peng-qing Wu, Xue-zhong Chen, & Qing Zhang (2025). Dyna-RR-DTC model: integrating clinicopathological features with dynamic indicators to predict radioiodine-refractory differentiated thyroid cancer risk. Annals of Nuclear Medicine. https://doi.org/10.1007/s12149-025-02119-3
Shi-qi Chen, et al. “Dyna-RR-DTC model: integrating clinicopathological features with dynamic indicators to predict radioiodine-refractory differentiated thyroid cancer risk.” Annals of Nuclear Medicine, 2025. doi:10.1007/s12149-025-02119-3.
@article{Chen2025,
title = {Dyna-RR-DTC model: integrating clinicopathological features with dynamic indicators to predict radioiodine-refractory differentiated thyroid cancer risk},
author = {Chen, Shi-qi and Jiang, Wei and Wu, Peng-qing and Chen, Xue-zhong and Zhang, Qing},
journal = {Annals of Nuclear Medicine},
year = {2025},
doi = {10.1007/s12149-025-02119-3},
url = {https://doi.org/10.1007/s12149-025-02119-3}
}